KoBioLabs, Inc (KOSDAQ:A348150) announced that it has received KRW 4,000,000,0000 in a round of funding fromCJ Cheiljedang Corporation (KOSE:A097950) in February 2019.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,570 KRW | +1.34% | -1.69% | -11.05% |
1st Jan change | Capi. | |
---|---|---|
-11.05% | 104M | |
+4.94% | 7.74B | |
+2.93% | 5.92B | |
-5.18% | 3.77B | |
-11.51% | 3.52B | |
-12.06% | 1.23B | |
-28.83% | 1.04B | |
+15.98% | 988M | |
-8.82% | 929M | |
-14.37% | 823M |
- Stock Market
- Equities
- A348150 Stock
- News KoBioLabs, Inc
- KoBioLabs, Inc announced that it has received KRW 4 billion in funding from CJ Cheiljedang Corporation